Moderna Inc (MRNA)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -3,561,000 | -4,714,000 | 8,362,000 | 12,202,000 | -747,064 |
| Revenue | US$ in thousands | 3,236,000 | 6,848,000 | 19,263,000 | 17,736,000 | 274,490 |
| Net profit margin | -110.04% | -68.84% | 43.41% | 68.80% | -272.16% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $-3,561,000K ÷ $3,236,000K
= -110.04%
The net profit margin of Moderna Inc has shown significant fluctuations over the years based on the provided data. In December 31, 2020, the company reported an alarming negative net profit margin of -272.16%, indicating that the company's expenses surpassed its revenue, leading to a substantial loss. However, by December 31, 2021, the net profit margin improved significantly to a positive 68.80%, indicating that the company was able to generate substantial profits relative to its revenue.
In the following years, Moderna Inc maintained a positive net profit margin, with fluctuations. By December 31, 2022, the net profit margin stood at 43.41%, indicating a slightly lower but still healthy level of profitability. However, in December 31, 2023, the net profit margin turned negative again, reaching -68.84%, suggesting a period of losses for the company.
The most recent data point, December 31, 2024, shows a further decline in profitability, with a net profit margin of -110.04%. This indicates that the company's expenses continued to outweigh its revenue, resulting in a significant loss.
Overall, the net profit margin of Moderna Inc has been volatile, reflecting the challenges and successes the company has experienced in its financial performance over the years.
Peer comparison
Dec 31, 2024